These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Autoimmune hepatitis in association with ramelteon. Fourman LT; Robert Meyer B J Clin Gastroenterol; 2013 Aug; 47(7):651-4. PubMed ID: 23632362 [TBL] [Abstract][Full Text] [Related]
4. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. Mini LJ; Wang-Weigand S; Zhang J Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and clinical safety of ramelteon: an evidence-based review. Sateia MJ; Kirby-Long P; Taylor JL Sleep Med Rev; 2008 Aug; 12(4):319-32. PubMed ID: 18603221 [TBL] [Abstract][Full Text] [Related]
7. Fresh from the pipeline: Ramelteon. Buysse D; Bate G; Kirkpatrick P Nat Rev Drug Discov; 2005 Nov; 4(11):881-2. PubMed ID: 16299918 [No Abstract] [Full Text] [Related]
8. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance]. Mishima K Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy. Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235 [TBL] [Abstract][Full Text] [Related]
10. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. Mini L; Wang-Weigand S; Zhang J Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991 [TBL] [Abstract][Full Text] [Related]
11. Ramelteon: TAK 375. Drugs R D; 2005; 6(3):186-8. PubMed ID: 15869323 [TBL] [Abstract][Full Text] [Related]
12. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. Miyamoto M CNS Neurosci Ther; 2009; 15(1):32-51. PubMed ID: 19228178 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of M-II, the major human metabolite of ramelteon. Nishiyama K; Nishikawa H; Kato K; Miyamoto M; Tsukamoto T; Hirai K Pharmacology; 2014; 93(3-4):197-201. PubMed ID: 24923230 [TBL] [Abstract][Full Text] [Related]
14. Ramelteon: a novel approach in the treatment of insomnia. Reynoldson JN; Elliott E; Nelson LA Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020 [TBL] [Abstract][Full Text] [Related]
16. [Melatonin agonist causes amplitude increase of the internal clock: for a productive day after a good night]. MMW Fortschr Med; 2009 Mar; 151(13):85. PubMed ID: 19504828 [No Abstract] [Full Text] [Related]
17. Ramelteon for the treatment of insomnia. Borja NL; Daniel KL Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111 [TBL] [Abstract][Full Text] [Related]
18. Ramelteon: a review of its use in insomnia. Simpson D; Curran MP Drugs; 2008; 68(13):1901-19. PubMed ID: 18729542 [TBL] [Abstract][Full Text] [Related]
19. [Recent and potential drugs for treatment of insomnia]. Terao A; Miyamoto M Nihon Yakurigaku Zasshi; 2007 Jan; 129(1):35-41. PubMed ID: 17220574 [No Abstract] [Full Text] [Related]
20. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests. Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]